Dr. Moises Roizental, MD

Dr. Roizental practices at Unique Interventional Radiology in North Miami Beach, Florida.

Dr. Roizental's NPI, 1568899896, was assigned on October 1, 2013. Dr. Roizental graduated from Central University of Venezuela in 1990. Dr. Roizental holds Florida license ME70024.

Dr. Roizental's primary practice is Unique Interventional Radiology, at 1380 Ne Miami Gardens Dr Ste 240, North Miami Beach, FL 33179. The practice phone is (305) 907-6191.

Dr. Roizental's primary practice is Unique Interventional Radiology in North Miami Beach, Florida. The medical group on file is David Galbut & Associates PA. Dmand AI also links Dr. Roizental to 1 more group practice or clinic and 1 medical group, each named with a free account. Dr. Roizental's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Roizental practices, 2 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Roizental's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Roizental is board certified in obesity medicine by the American Board of Obesity Medicine. Dmand AI has Dr. Roizental's licenses on file in 2 states: Florida and Massachusetts.

CMS data shows 416 Medicare services from Dr. Roizental across 8 procedure codes in 2024, for 112 Medicare patients. Medicare paid $81,204 for them. Every service was in an office.

CMS counts 112 Medicare patients who saw Dr. Roizental in 2024. The largest group is 75 to 84, with 41 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 3.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Roizental's median patient age at 53, with 74% women.

In 2024, Dr. Roizental wrote 40 Medicare Part D claims for 13 patients. 93% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $85 in total drug cost. In 2023, CMS named 34 claims across 1 drug.

Dr. Roizental accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 16 procedures of varicose vein removal by Dr. Roizental, more than 52% of the clinicians it reports for that procedure.

Dmand AI links 17 papers to Dr. Roizental. The most frequent topics are Radiography, Interventional, Catheterization, Central Venous and Catheterization, Peripheral.

CMS Open Payments shows 57 general payments to Dr. Roizental from 17 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 53% of the total. Guerbet LLC paid the most, $7,659.

Dmand AI lists 9 awards for Dr. Roizental, most recently Best Poster Award in 2014.

Dr. Roizental graduated from Central University of Venezuela in 1990. Dr. Roizental is a member of ACP, RSNA, SIDI and SIR.

Dr. Roizental is in network with 9 carriers, including Excellus BlueCross BlueShield, United Healthcare and Elevance. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.